4
Changes in Ownership
Alaunos Therapeutics, Inc. Filed Acc 0001140361-18-027082
Options or other derivatives
- Director acquired 1,245 shares (other)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| KIRK RANDAL J Director | 2018-05-31 | Other acquisition · Series 1 Preferred Stock | +1,245 | 125,745 | I | ||
Loading xslF345X03/doc1.xml…